Bringing Exposure Therapy to Real-Life Context With Augmented Reality
NCT03649347 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2022-04-19
Summary
In this patented project, U.S. Patent No. 10,839,707, the investigators will develop an augmented reality exposure therapy method for arachnophobia, and fear of snakes, to test in the clinic. The platform will include a software that allows the clinician (psychiatrist/therapist) to position virtual objects in the real environment of the patient with the above mentioned phobias while the patient is wearing the augmented reality (AR) device. Then the clinician will lead the patient through steps of exposure therapy to the fear objects. The investigators will then measure the impact of treatment and compare to before treatment measures of fear of the phobic object.
Exposure therapy is the most evidence-based treatment for specific phobias, social phobia, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD). The core principle is patient's exposure to the feared objects/situations guided by a clinician. For example, in arachnophobia, patient is exposed to pictures of spiders printed or on a computer screen- or if available, view of a real tarantula in the office. Gradually, patient tolerates viewing/approaching the spider from a closer distance, and fear response extinguishes. The clinician has a crucial role in signaling safety to the patient, as well as providing support and coaching. This treatment is limited by multiple factors: 1) limited access to feared objects/situations in the clinic, 2) even when feared objects are available, they are not diverse (e.g. different types and colors of spiders), which limits generalization of safety learning, 3) when available, clinician has very limited control over behaviors of the feared objects (e.g. spider/snake), 4) safety learning is limited to the clinic office context, and contextualization of safety learning to real life experiences is left to the patient to do alone, which often does not happen. This is specifically important in conditions such as PTSD, where there is cumulative evidence for impaired contextualization as a key neurobiological underpinning. 5) Lack of geographical access to experts in exposure therapy, especially for PTSD, in rural areas.
Conditions
- Phobias Snakes
- Phobias Spiders
Interventions
- BEHAVIORAL
-
Augmented reality exposure therapy
Exposure therapy via utilization of augmented reality. Virtual objects will be placed on the patient's real environment for exposure therapy.
Sponsors & Collaborators
-
Wayne State University
lead OTHER
Principal Investigators
-
Arash Javanbakht, MD · Wayne State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-30
- Primary Completion
- 2020-04-01
- Completion
- 2020-04-01
Countries
- United States
Study Locations
More Related Trials
-
D-Cycloserine and Virtual Reality Exposure Therapy
NCT02933684 ·Status: WITHDRAWN ·Phase: PHASE2
-
Virtual Reality Exposure in Spider Phobia
NCT03208400 ·Status: COMPLETED ·Phase: NA
-
Use of Safety Behaviors in Exposure Therapy for Arachnophobia
NCT04470882 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Virtual Reality for Providing Exposure Therapy to Children
NCT03208348 ·Status: COMPLETED ·Phase: NA
-
Feasibility of an Online Modeled Exposure in Spider Fearful Individuals
NCT06182709 ·Status: COMPLETED ·Phase: NA
-
Spider Phobia Opposite Action Treatment Study
NCT02905279 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
NCT04663672 ·Status: COMPLETED ·Phase: NA
-
Neurophysiological Correlates of Exposition Therapy in Spider Phobia
NCT03653923 ·Status: UNKNOWN ·Phase: NA
-
Effects of Stress on Exposure Therapy
NCT03505437 ·Status: COMPLETED ·Phase: NA
-
Gamification in the Treatment of Spider Phobia
NCT04423783 ·Status: COMPLETED ·Phase: NA
-
Improving the Efficacy of Exposure Therapy for the Treatment of Cockroach Phobia
NCT04563403 ·Status: RECRUITING ·Phase: NA
-
Smartphone-based Virtual Reality Exposure and Standard Relaxation Training for Anxiety on an Inpatient Psychiatric Unit
NCT05050123 ·Status: TERMINATED ·Phase: NA
-
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
NCT03683472 ·Status: COMPLETED ·Phase: NA
-
Social Anxiety Virtual Reality Study
NCT04288180 ·Status: TERMINATED
-
Optimizing Exposure Therapy With Mental Rehearsal
NCT03934385 ·Status: COMPLETED ·Phase: NA
-
Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD
NCT02713516 ·Status: COMPLETED ·Phase: NA
-
Optimizing Exposure Using Occasional Aversive Imagery in Spider Fearful Individuals
NCT05424250 ·Status: COMPLETED ·Phase: NA
-
Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure
NCT03907345 ·Status: COMPLETED ·Phase: NA
-
Virtual Reality Exposure Therapy for the Treatment of Social Phobia
NCT02379949 ·Status: COMPLETED ·Phase: NA
-
tDCS-Augmented Exposure Therapy for Pathological Fear
NCT03095482 ·Status: COMPLETED ·Phase: NA
-
Extinction Generalization in Exposure Therapy
NCT03031002 ·Status: COMPLETED ·Phase: NA
-
iExposure Intervention for Social Anxiety
NCT06409247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
NCT04850989 ·Status: COMPLETED ·Phase: NA
-
Augmentation Study of A Computerized Treatment for Social Anxiety Disorder
NCT02372019 ·Status: COMPLETED ·Phase: NA